387,388 Shares in Teleflex Incorporated $TFX Bought by Boone Capital Management LLC

Boone Capital Management LLC bought a new position in shares of Teleflex Incorporated (NYSE:TFX) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 387,388 shares of the medical technology company’s stock, valued at approximately $49,105,000. Teleflex accounts for about 11.5% of Boone Capital Management LLC’s investment portfolio, making the stock its largest holding. Boone Capital Management LLC owned approximately 0.91% of Teleflex at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Universal Beteiligungs und Servicegesellschaft mbH raised its position in Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock valued at $3,395,000 after buying an additional 19,327 shares during the period. First Eagle Investment Management LLC boosted its position in Teleflex by 163.4% during the 4th quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company’s stock worth $10,288,000 after acquiring an additional 52,300 shares during the period. Baader Bank Aktiengesellschaft boosted its position in Teleflex by 32.4% during the 4th quarter. Baader Bank Aktiengesellschaft now owns 43,333 shares of the medical technology company’s stock worth $5,288,000 after acquiring an additional 10,600 shares during the period. Diamond Hill Capital Management Inc. grew its stake in Teleflex by 6.3% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 349,809 shares of the medical technology company’s stock valued at $42,691,000 after acquiring an additional 20,773 shares in the last quarter. Finally, Fifth Third Bancorp grew its stake in Teleflex by 3,204.8% during the 1st quarter. Fifth Third Bancorp now owns 68,144 shares of the medical technology company’s stock valued at $8,151,000 after acquiring an additional 66,082 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Down 1.1%

NYSE:TFX opened at $138.69 on Thursday. The company has a market capitalization of $5.88 billion, a P/E ratio of -5.95, a P/E/G ratio of 0.93 and a beta of 0.81. The stock’s 50 day moving average price is $133.39 and its 200 day moving average price is $125.61. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $145.00.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company’s revenue was up 28.9% compared to the same quarter last year. During the same period in the previous year, the company earned $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, research analysts forecast that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex’s payout ratio is presently -5.84%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research reports. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a report on Sunday, August 9th. UBS Group raised their price target on shares of Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. BMO Capital Markets began coverage on shares of Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Raymond James Financial reiterated an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research note on Friday, May 8th. Finally, Truist Financial increased their target price on shares of Teleflex from $143.00 to $150.00 and gave the stock a “hold” rating in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $152.90.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.